- Blood Sugar
- Clinical Studies
- Complementary Medicine
- Diabetes and Men
- Erectile Dysfunction
- Food and Nutrition
- Insulin Pumps
- Meters and Test Strips
- Product Recalls
- Type 1
- Type 2
- Weight Loss Surgery
August 20, 2014 (Medscape) - Low plasma adiponectin levels in patients with acute myocardial infarction (MI) are independently associated with an increased risk of subsequent diabetes, according to Danish researchers.
As Dr. Soren Lindberg told Reuters Health by email, "Patients with myocardial infarction have a high risk of developing type 2 diabetes. Measurement of adiponectin could possible complement measurement of blood-glucose and/or HbA1c in order to identify patients with type 2 diabetes or impaired glucose tolerance
August 20, 2014 (Healio) - Elevated glucose measurements discovered during an emergency hospital admission could predict the risk for developing type 2 diabetes, particularly in people older than 40 years of age, according to research published in PLOS Medicine.
The findings could inform patients of long-term risk and target lifestyle advice to those at highest risk, according to the s
August 20, 2014 (Reuters) - The U.S. Food and Drug Administration granted tentative approval for Eli Lilly and Co and Boehringer Ingelheim's insulin injection that helps control blood sugar levels in diabetes patients, Lilly said in a statement.
The drug, Basaglar, is intended to provide long-lasting blood sugar control in between meals and during the night. It is approved for adults with type 2 diabetes and in combination with mealtime insulin in adults and children with type 1 diabetes.
August 20, 2014 (Healio) - Women with type 2 diabetes and already at risk for heart disease had a 30% reduction in adverse cardiovascular outcomes with the cholesterol-lowering drug fenofibrate, according to research published in Diabetologia.
Treatment with fenofibrate also demonstrated a 24 percent decrease in adverse outcomes for men with the chronic disease, providing
August 18, 2014 (Medscape) - About 40% of US adults will develop diabetes, primarily type 2, in their lifetime, and over 50% of some ethnic minorities will be affected, according to new research from the Centers for Disease Control and Prevention (CDC) and Emory University, Atlanta, Georgia, published online August 13 in Lancet Diabetes & Endocrinology.
This is substantially higher than previous estimates that were based on incidence and mortality from the 1990s, say the researchers.
"We have found that over th